A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
This pilot study is a feasibility, safety, and preliminary benefits study to look at whether
giving the calcium channel blocker amlodipine to people with hereditary pancreatitis as a
prophylactic measure can reduce the inflammatory process in the pancreas.